What is the structure of Anatomic Pathology Market and who are the key players?
According to our latest research study on “Anatomic Pathology Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product and Service, Application, and End User”, the market is projected to reach reach US$ 33,145.78 million by 2028 from US$ 21,488. 41 million in 2021; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. The report highlights trends prevailing in the market and the factors governing the market growth.
Get Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00002999/
Anatomic pathology is devoted to studying diseases and disease progression based on the macroscopic, microscopic, biochemical, immunologic, and molecular examination of organs and tissues. It entails evaluations of tissue specimens, including cervical scrapings (i.e., PAP smears); biopsies; surgical resections; and whole-body evaluations after autopsy. Factors such as increase in the prevalence of cancer and other diseases, and growing focus on personalized medicines are boosting the market growth. However, the lack of skilled professionals and stringency of government regulations hamper the market growth.
Based on application, the anatomic pathology market has been segmented into disease diagnosis, drug discovery and development, and others. The disease diagnosis segment is expected to hold the largest share of the market in 2021, whereas the drug discovery and development segment is expected to register the highest CAGR during the forecast period. Anatomic pathology is majorly used for diagnosing various diseases, including tumors or cancers, kidney and liver diseases, autoimmune disorders, and infections. It assists in the studying the effects of diseases on the human body, post autopsy and microscopic examination of tissues, cells, and other specimens. The anatomic pathology-based disease diagnostic services includes necropsy / deceased care center, cytopathology, electron microscopy, histopathology, immunopathology, and surgical pathology. Surge in the prevalence of various chronic diseases would propel the adoption of these services, especially histopathology and cytopathology, in diagnosis applications. For instance, the COVID-19 outbreak has led to a surge in the demand for emergency testing and diagnostic services, such as immunopathology.
- Hoffmann-La Roche AG, Danaher, Hologic, Inc, Agilent Technologies Inc, BioGenex, Diapath S.p.A, Bio SB, Merck KGaA, BD, and PHC Holdings Corporation are among the leading companies operating in the anatomic pathology market.
The report segments global anatomic pathology market as follows:
Anatomic Pathology Market – by Product and Service
- Microtomes and Cryostat
- Automatic Stainers
- Tissue Processors
- Other Products
Anatomic Pathology Market – by Application
- Disease Diagnosis
- Drug Discovery & Development
Anatomic Pathology Market – by End User
- Research Laboratories
- Diagnostic Laboratories
Our Most Selling Reports
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: [email protected]